CN101817867B - 一种甘草次酸的制备方法 - Google Patents
一种甘草次酸的制备方法 Download PDFInfo
- Publication number
- CN101817867B CN101817867B CN 201010183738 CN201010183738A CN101817867B CN 101817867 B CN101817867 B CN 101817867B CN 201010183738 CN201010183738 CN 201010183738 CN 201010183738 A CN201010183738 A CN 201010183738A CN 101817867 B CN101817867 B CN 101817867B
- Authority
- CN
- China
- Prior art keywords
- acid
- glycyrrhetinic acid
- organic solvent
- glycyrrhetinic
- filter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 title claims abstract description 107
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 title claims abstract description 55
- 229960003720 enoxolone Drugs 0.000 title claims abstract description 54
- 238000000034 method Methods 0.000 title abstract description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 39
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 30
- 239000000284 extract Substances 0.000 claims abstract description 24
- 230000007062 hydrolysis Effects 0.000 claims abstract description 22
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 22
- 239000003960 organic solvent Substances 0.000 claims abstract description 22
- 238000004128 high performance liquid chromatography Methods 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 238000010992 reflux Methods 0.000 claims abstract description 14
- FTQDJVZNPJRVPG-XWEVEMRCSA-N Acetoxolone Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](OC(=O)C)C1(C)C FTQDJVZNPJRVPG-XWEVEMRCSA-N 0.000 claims abstract description 12
- 229960004871 acetoxolone Drugs 0.000 claims abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 10
- 239000002253 acid Substances 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 238000006386 neutralization reaction Methods 0.000 claims abstract description 8
- 239000003513 alkali Substances 0.000 claims abstract description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 36
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 17
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 16
- 238000005406 washing Methods 0.000 claims description 16
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- 239000007787 solid Substances 0.000 claims description 8
- 238000001953 recrystallisation Methods 0.000 claims description 6
- 206010013786 Dry skin Diseases 0.000 claims description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 5
- 238000004090 dissolution Methods 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 229910017053 inorganic salt Inorganic materials 0.000 claims description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- 239000003377 acid catalyst Substances 0.000 claims description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims description 2
- 239000012065 filter cake Substances 0.000 claims description 2
- 238000005516 engineering process Methods 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 230000021736 acetylation Effects 0.000 abstract 1
- 238000006640 acetylation reaction Methods 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 230000003197 catalytic effect Effects 0.000 abstract 1
- 238000006555 catalytic reaction Methods 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 235000019441 ethanol Nutrition 0.000 description 12
- 239000012535 impurity Substances 0.000 description 11
- 229960000583 acetic acid Drugs 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 238000002386 leaching Methods 0.000 description 6
- 238000001914 filtration Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 4
- 244000303040 Glycyrrhiza glabra Species 0.000 description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 3
- -1 Glycyrrhizinic acid monopotassium salt Chemical class 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- 235000011477 liquorice Nutrition 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 101000672034 Bacillus sp. (strain GL1) Unsaturated glucuronyl hydrolase Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 102400000336 Thyrotropin-releasing hormone Human genes 0.000 description 1
- 101800004623 Thyrotropin-releasing hormone Proteins 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003699 antiulcer agent Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 150000002342 glycyrrhetinic acids Chemical class 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- XNSAINXGIQZQOO-SRVKXCTJSA-N protirelin Chemical compound NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-SRVKXCTJSA-N 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010183738 CN101817867B (zh) | 2010-05-27 | 2010-05-27 | 一种甘草次酸的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010183738 CN101817867B (zh) | 2010-05-27 | 2010-05-27 | 一种甘草次酸的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101817867A CN101817867A (zh) | 2010-09-01 |
CN101817867B true CN101817867B (zh) | 2012-12-05 |
Family
ID=42653158
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201010183738 Active CN101817867B (zh) | 2010-05-27 | 2010-05-27 | 一种甘草次酸的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101817867B (zh) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103588849A (zh) * | 2012-08-14 | 2014-02-19 | 江苏汉邦科技有限公司 | 一种甘草次酸的制备方法 |
CN104004046A (zh) * | 2014-05-27 | 2014-08-27 | 普凡生生物科技(北京)有限公司 | 一种乙酰甘草次酸的制备方法 |
CN104004047A (zh) * | 2014-05-27 | 2014-08-27 | 普凡生生物科技(北京)有限公司 | 一种甘草次酸的制备方法 |
CN104497093A (zh) * | 2014-11-25 | 2015-04-08 | 普凡生生物科技(北京)有限公司 | 一种甘草次酸的制备方法 |
CN104861030A (zh) * | 2015-03-01 | 2015-08-26 | 李玉山 | 一种双相水解法制备甘草次酸的方法 |
CN104829681A (zh) * | 2015-05-08 | 2015-08-12 | 江苏天晟药业有限公司 | 一种甘草次酸的提纯方法 |
CN105669823A (zh) * | 2016-03-04 | 2016-06-15 | 南京大学 | 一类含哌嗪骨架的甘草次酸衍生物、其制备方法及应用 |
CN106543261A (zh) * | 2016-10-27 | 2017-03-29 | 深圳市新阳唯康科技有限公司 | 一种甘草次酸晶型物质及其制备方法 |
CN106565817A (zh) * | 2016-11-09 | 2017-04-19 | 深圳市新阳唯康科技有限公司 | 一种无定型甘草次酸及其制备方法 |
CN106749485A (zh) * | 2016-11-25 | 2017-05-31 | 深圳市新阳唯康科技有限公司 | 一种甘草次酸新晶型及其制备方法 |
CN106632575A (zh) * | 2016-12-20 | 2017-05-10 | 深圳市新阳唯康科技有限公司 | 一种甘草次酸新晶型及其制备方法 |
CN107058443A (zh) * | 2017-06-07 | 2017-08-18 | 江苏天晟药业股份有限公司 | 一种甘草次酸的制备方法 |
CN110090469A (zh) * | 2019-04-26 | 2019-08-06 | 青岛农业大学 | 一种从甘草中提取纯化甘草素和甘草次酸的方法 |
CN110283225B (zh) * | 2019-07-29 | 2021-02-02 | 洛阳蓝斯利科技有限公司 | 一种24-羟基-甘草次酸的制备方法 |
CN111620924A (zh) * | 2020-06-04 | 2020-09-04 | 华中农业大学 | 基于天然产物的药物设计方法、五环三萜类化合物、其制备方法及应用 |
CN114507269A (zh) * | 2022-03-07 | 2022-05-17 | 新疆富沃药业有限公司 | 一种乙酰甘草次酸的制备方法 |
CN115772205A (zh) * | 2022-11-18 | 2023-03-10 | 江苏天晟药业股份有限公司 | 一种硬脂醇甘草亭酸酯绿色制备工艺 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1563073A (zh) * | 2004-04-06 | 2005-01-12 | 南开大学 | 甘草次酸的制备方法 |
CN101508719A (zh) * | 2009-03-31 | 2009-08-19 | 南京工业大学 | 11-脱氧甘草次酸-3-0-丁二酸半酯稀土盐及其合成方法 |
-
2010
- 2010-05-27 CN CN 201010183738 patent/CN101817867B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1563073A (zh) * | 2004-04-06 | 2005-01-12 | 南开大学 | 甘草次酸的制备方法 |
CN101508719A (zh) * | 2009-03-31 | 2009-08-19 | 南京工业大学 | 11-脱氧甘草次酸-3-0-丁二酸半酯稀土盐及其合成方法 |
Non-Patent Citations (2)
Title |
---|
余方等.从甘草中提取甘草酸制备甘草次酸的研究进展.《江西农业学报》.2008,第20卷(第08期),91-94. * |
彭子模.甘草次酸及其衍生物的研究现状和展望.《中医药学报》.1998,(第01期),32-35. * |
Also Published As
Publication number | Publication date |
---|---|
CN101817867A (zh) | 2010-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101817867B (zh) | 一种甘草次酸的制备方法 | |
CN102408314B (zh) | 一种制备高纯度厚朴酚与和厚朴酚的方法 | |
CN110845328A (zh) | 一种以迷迭香油膏副产品制备高纯度鼠尾草酸的方法 | |
CN104784254A (zh) | 一种生物酶法生产黄芩苷的提取方法 | |
KR101158535B1 (ko) | 감초 또는 감초 추출물에서의 개선된 리퀴리티게닌의 추출 방법 | |
CN101012230A (zh) | 斑蝥酸钠的制备工艺 | |
CN101591680A (zh) | 氧化白藜芦醇的提取方法 | |
CN103145668A (zh) | 一种橙皮苷制备木犀草素的新技术 | |
CN100577676C (zh) | 6-o-咖啡酰基熊果苷提取方法 | |
CN101914002A (zh) | 一种蓝萼甲素的提取方法 | |
CN101327232A (zh) | 一种采用聚酰胺分离纯化沙棘黄酮的制备方法及其应用 | |
CN101781215A (zh) | 棓丙酯原料药化学半合成制备方法 | |
CN101205249B (zh) | 从黑刺菝葜植物中制备拉肖皂苷元的方法 | |
CN113429452B (zh) | 一种作为抗炎剂的罗汉果酸酰化衍生物以及一种抗炎组合物 | |
CN102697838B (zh) | 从黄芪中同时提取和分离黄酮富集物、皂苷富集物和多糖的方法 | |
CN109806265A (zh) | 一种新的三七皂苷制剂及其用途 | |
CN113603704B (zh) | 从甜茶苷生产的副产物中分离鞣花酸的酶法制备方法 | |
CN102659904B (zh) | 一种常春藤皂苷元及其盐的制备方法 | |
CN101891729B (zh) | 一种从青天葵中提取高纯度鼠李秦素的方法 | |
CN104592322A (zh) | 一种从仙茅属植物提取分离仙茅苷的方法 | |
CN103012072A (zh) | 一种高纯和厚朴酚与厚朴酚制备技术 | |
CN102603852A (zh) | 一种雷公藤红素的制备方法 | |
CN113444103A (zh) | 一种从山茱萸中提纯脱水莫诺苷元的方法 | |
CN102618593B (zh) | 一种利用黑曲霉水解灯盏乙素制备野黄芩素的方法 | |
CN102093323A (zh) | 槲皮素的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: GANSU FANZHI BIOLOGICAL TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: GAO YING Effective date: 20150518 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150518 Address after: 730010 Lanzhou, Gansu hi tech Zone Innovation Park Venture Building, block A, floor 9 Patentee after: Gansu pan Biological Technology Co., Ltd. Address before: 730010 Lanzhou, Gansu hi tech Zone Innovation Park Venture Building, block A, floor 9 Patentee before: Gao Ying |
|
CP03 | Change of name, title or address |
Address after: 730200 Gansu city of Lanzhou province Gaolan County town of cave Sanchuan Industrial Park (South East Village soil in Longchuan) Patentee after: Gansu pan Pharmaceutical Co., Ltd. Address before: 730010 Lanzhou, Gansu hi tech Zone Innovation Park Venture Building, block A, floor 9 Patentee before: Gansu pan Biological Technology Co., Ltd. |
|
CP03 | Change of name, title or address |